Exocyclic C-C Modifications of Aromatic Polyketides
芳香族聚酮化合物的环外C-C修饰
基本信息
- 批准号:7009317
- 负责人:
- 金额:$ 28.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-01-18 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Aromatic polyketides differ from other polyketides by their characteristic polycyclic aromatic structures. These polyketides are widely distributed in bacteria, fungi and plants, and many of them are clinically valuable agents (e.g. tetracyclines, daunorubicin) or exhibit other fascinating biological activities. While the fundamental biosynthetic principles of aromatic polyketides has been extensively explored, little is known regarding the construction of many existing unique exocyclic carbon-carbon (C-C) attachments to these metabolites. The current proposal is designed to expand our understanding of this phenomenon by bringing together the study of two naturally occurring novel aromatic polyketide systems, which promise access to three distinct exocyclic aromatic polyketide C-C modifications. The first, hedamycin from Streptomyces griseoruber, offers one of the only naturally occurring di-C-glycosylation events as well as an additional type I PKS-directed C-alkyl chain substitution of the polycyclic ring system. The second, dynemicin from Micromonospora chersina, offers the only known naturally occurring fusion between an enediyne and aromatic polyketide. The intended studies are expected to lay a foundation to understand the unique mechanisms of these processes and also the potential to utilize these tools for combinatorial biosynthesis toward novel therapeutics. The first phase of this massive project is specifically intended to i) provide the necessary genetic tools and information to form reasonable mechanistic hypotheses for all three events, ii) to initiate in vivo and in vitro experiments explicitly designed to address the C-glycosylation and C-alkylation stages of hedamycin/pluramycin biosynthesis and Hi) attempt to combine aspects of all three aromatic C-C modification systems toward enhancing the diversification of aromatic polyketide structures. A particular focus of the final diversification strategies presented will be focused upon conjugation of these highly reactive antitumor antibiotics with known tumor-directing peptides.
描述(由申请人提供):芳香族聚酮化合物与其他聚酮化合物的不同之处在于其特征性的多环芳香族结构。这些聚酮化合物广泛分布于细菌、真菌和植物中,其中许多是有临床价值的药物(如四环素类、柔红霉素)或表现出其他迷人的生物活性。虽然芳香族聚酮化合物的基本生物合成原理已被广泛探索,但关于这些代谢物的许多现有独特的环外碳-碳(C-C)连接的构建知之甚少。目前的建议旨在扩大我们对这一现象的理解,通过将两种天然存在的新型芳香族聚酮系统的研究结合在一起,这两种系统有望获得三种不同的环外芳香族聚酮C-C修饰。第一种是来自灰红链霉菌的hedamycin,它提供了仅有的天然存在的二-C-糖基化事件之一以及多环系统的另外的I型PKS-指导的C-烷基链取代。第二,动力霉素从小单孢菌chersina,提供了唯一已知的自然发生的融合之间的烯二炔和芳香族聚酮。预期的研究将为理解这些过程的独特机制以及利用这些工具进行组合生物合成以获得新疗法的潜力奠定基础。这个大规模项目的第一阶段特别旨在i)提供必要的遗传工具和信息,以形成所有三个事件的合理机制假设,ii)启动明确设计用于解决海达霉素/普朗霉素生物合成的C-糖基化和C-烷基化阶段的体内和体外实验,C改性系统,以提高芳香族聚酮化合物结构的多样化。提出的最终多样化策略的一个特别重点将集中在这些高反应性抗肿瘤抗生素与已知的肿瘤导向肽的缀合上。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jon Scott Thorson其他文献
Jon Scott Thorson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jon Scott Thorson', 18)}}的其他基金
Administrative Supplement: COBRE in Pharmaceutical Research and Innovation
行政补充:COBRE 药物研究与创新
- 批准号:
10399734 - 财政年份:2021
- 资助金额:
$ 28.08万 - 项目类别:
Administrative Supplement: COBRE in Pharmaceutical Research and Innovation
行政补充:COBRE 药物研究与创新
- 批准号:
10582060 - 财政年份:2020
- 资助金额:
$ 28.08万 - 项目类别:
Center of Biomedical Research Excellence in Pharmaceutical Research and Innovation
药物研究与创新卓越生物医学研究中心
- 批准号:
10333385 - 财政年份:2020
- 资助金额:
$ 28.08万 - 项目类别:
Administrative Supplement: COBRE in Pharmaceutical Research and Innovation
行政补充:COBRE 药物研究与创新
- 批准号:
10794454 - 财政年份:2020
- 资助金额:
$ 28.08万 - 项目类别:
Center of Biomedical Research Excellence in Pharmaceutical Research and Innovation
药物研究与创新卓越生物医学研究中心
- 批准号:
10569658 - 财政年份:2020
- 资助金额:
$ 28.08万 - 项目类别:
Center of Biomedical Research Excellence in Pharmaceutical Research and Innovation
药物研究与创新卓越生物医学研究中心
- 批准号:
10112923 - 财政年份:2020
- 资助金额:
$ 28.08万 - 项目类别:
Biosynthesis and medicinal chemistry of the capuramycin antimycobacterial antibiotics
辣椒霉素抗分枝杆菌抗生素的生物合成和药物化学
- 批准号:
9246017 - 财政年份:2017
- 资助金额:
$ 28.08万 - 项目类别:
相似国自然基金
TLS聚合酶Polη乙酰化修饰的动态调控和功能研究
- 批准号:31970740
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
相似海外基金
Greasing endocytosis in plants - understanding the role of S-acylation in receptor kinase function and internalisation
植物中的润滑内吞作用 - 了解 S-酰化在受体激酶功能和内化中的作用
- 批准号:
BB/Y003756/1 - 财政年份:2024
- 资助金额:
$ 28.08万 - 项目类别:
Research Grant
Ghrelin de-acylation inhibitors as novel compounds for Parkinson's dementia
生长素释放肽去酰化抑制剂作为治疗帕金森痴呆症的新型化合物
- 批准号:
MR/Y503435/1 - 财政年份:2024
- 资助金额:
$ 28.08万 - 项目类别:
Research Grant
Discovery of phosgene and chlorine gas modes of action and therapeutic targets using chemoproteomic profiling strategies
使用化学蛋白质组学分析策略发现光气和氯气的作用模式和治疗靶点
- 批准号:
10883970 - 财政年份:2023
- 资助金额:
$ 28.08万 - 项目类别:
Time-restricted eating: Is it an efficacious tool for weight loss maintenance
限时饮食:是减肥维持的有效工具吗
- 批准号:
10591316 - 财政年份:2023
- 资助金额:
$ 28.08万 - 项目类别:
Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
- 批准号:
10603466 - 财政年份:2023
- 资助金额:
$ 28.08万 - 项目类别:
Examination of Ornithine Decarboxylase Antizyme RNA Structure and Function from Various Organisms for the Development of Antibiological Agents
检查不同生物体的鸟氨酸脱羧酶抗酶 RNA 结构和功能,用于开发抗生素
- 批准号:
10730595 - 财政年份:2023
- 资助金额:
$ 28.08万 - 项目类别:
Multiomics data integration methods to discover putative causal variants, genes and patient heterogeneity for Alzheimers disease
多组学数据整合方法发现阿尔茨海默病的假定因果变异、基因和患者异质性
- 批准号:
10587524 - 财政年份:2023
- 资助金额:
$ 28.08万 - 项目类别:
Chemical Synthesis and Biological Application of Carbohydrates and Glycoconjugates
碳水化合物和糖复合物的化学合成和生物应用
- 批准号:
10552167 - 财政年份:2023
- 资助金额:
$ 28.08万 - 项目类别: